F901318 Single Ascending Dose Study in Healthy Male Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
F901318 is a potent new antifungal agent for the treatment of systemic fungal infections. This study will test it for the first time in man with the objective of assessing its safety, tolerability and pharmacokinetic profile.
Epistemonikos ID: 6028c5a6dbe18ba0b974369de34c38eb37ab3502
First added on: May 11, 2024